StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.06−0.44 (-12.57%)

Close on Nov 18, 2026Market cap $62.83KP/E –Yield –

Addex Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Addex Therapeutics's price to sales ratio was 1.7× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 3.7×, with a median of 0.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×+1.4
2025Dec 31, 20250.3×+0.2
2024Dec 31, 20240.1×+0.0
2023Dec 29, 20230.0×+0.0
2022Dec 30, 20220.0×−0.1
2021Dec 31, 20210.1×−0.2
2020Dec 31, 20200.3×–

More Addex Therapeutics figures

See a number that looks wrong?